Brief: Kilitch Drugs (India) Approves Continuation Of Mukund Mehta As MD
March 15 (Reuters) - Kilitch Drugs (India) Ltd
KIDI.NS :
* APPROVED CONTINUATION OF APPOINTMENT OF MUKUND MEHTA AS MD
Source text for Eikon: ID:nNSE3srXsG
Further company coverage: KIDI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kilitch Drugs (India)
See all newsBrief: Kilitch Drugs (India) To Consider Approval To Sell Entire Shareholding In Unit
Brief: Kilitch Drugs To Divest Entire Stake In Kilitch Estro Biotech PLC
Brief: Kilitch Drugs (India) To Issue Bonus Shares In Ratio Of 1:1
Brief: Kilitch Drugs (India) Approves Issue Price For Rights Issue At 357 Rupees Per Share
Brief: Kilitch Drugs (India) To Raise Up To 500 Million Rupees Via Rights Issue